the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Clinical trial NCT06622603 · RECRUITING
Trial details
- NCT number
- NCT06622603
- Sponsor
- Seoul National University Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2027-02-19
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.